Characteristics and outcomes of the drug patent linkage system in China
Abstract Background On July 4, 2021, China officially introduced the drug patent linkage system, which has made more localized adjustments than have similar systems in the US and South Korea. This study describes the characteristics and outcomes of China's patent linkage system. Methods For thi...
Saved in:
Main Author: | Xue-Fang Yao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patenting and patent challenges in South Korea after introducing a patent linkage system
by: Kyung-Bok Son
Published: (2022) -
Patent challenges and factors associated with successful patent challengers under the patent linkage system: recent evidence from South Korea after the Korea United States free trade agreement
by: Kyung-Bok Son, et al.
Published: (2021) -
Perceived impact of the patent linkage system on pharmaceutical market from the viewpoint of the domestic manufacturers in South Korea
by: Nahye Choi, et al.
Published: (2022) -
Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?
by: Kyung-Bok Son
Published: (2023) -
The Legislative Approach and System Improvement of China’s Compulsory Licensing for Drug Patents
by: Cao Z, et al.
Published: (2021)